Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2023-09-12 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
祥生医疗2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the company's 2023 second extraordinary general meeting of shareholders. It details the meeting date, attendance, voting results, and legal witness statements. The content focuses on the voting outcomes and procedural compliance rather than presenting a full report or financial statements. The document length is short (1632 characters) and it is clearly an announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-09-12 Chinese
上海市通力律师事务所关于无锡祥生医疗科技股份有限公司2023年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 second extraordinary general meeting (临时股东大会) of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the legality and validity of the meeting's convening, attendance, voting procedures, and results. The document includes voting results on a share repurchase proposal and confirms the meeting's compliance with laws and company bylaws. It is not the meeting materials themselves, nor a report of financial results, but a legal opinion on the meeting process and outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting.
2023-09-12 Chinese
祥生医疗关于回购股份事项前十大股东和前十大无限售条件股东持股信息的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the top ten shareholders and top ten unrestricted shareholders as of the record date for a share repurchase plan. It references a board meeting approving a share repurchase plan and a notice of an extraordinary shareholders meeting. The content focuses on shareholder holdings and share repurchase details, which aligns with disclosures related to share buybacks or capital changes. The document length is short (1549 characters) and it is not a full financial report or earnings release. It is not a report publication announcement since it contains substantive shareholder data. Therefore, the document fits best under the category of Transaction in Own Shares (POS), which covers company announcements about share repurchases or sales of own shares.
2023-09-08 Chinese
祥生医疗关于回购股份事项前十大股东和前十大无限售条件股东持股信息的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the top ten shareholders and top ten unrestricted shareholders before a share repurchase plan. It references a previously disclosed share repurchase plan and provides detailed shareholding information as of a specific date. The content focuses on shareholding changes related to a share buyback, not on financial results, management changes, or regulatory certifications. The document length is short (1473 characters) and it is a formal announcement of shareholding information in relation to a share repurchase. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2023-09-01 Chinese
无锡祥生医疗科技股份有限公司2023年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2023 Second Extraordinary General Meeting" of Wuxi Xiangsheng Medical Technology Co., Ltd. It contains detailed information about the meeting agenda, voting procedures, and a specific proposal regarding a share repurchase plan through centralized bidding. The content includes the proposal's background, purpose, terms, risks, and authorization details. This is clearly a document prepared for a shareholders' meeting, providing materials and information for the meeting attendees to review and discuss. It is not a report of financial results, audit, or earnings, nor is it a transcript or announcement of voting results. It is not a proxy solicitation or a regulatory filing. The document is a presentation of materials for a shareholders meeting, specifically an extraordinary general meeting (EGM). According to the filing definitions, materials shared during a general meeting (AGM or EGM) fall under "AGM Information (AGM-R)". Therefore, the correct classification is AGM-R with high confidence.
2023-09-01 Chinese
祥生医疗关于召开2023年半年度医疗设备专场集体业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about a scheduled half-year performance explanation meeting (业绩说明会) for the 2023 half-year period, organized by Wuxi Xiangsheng Medical Technology Co., Ltd. It mentions the date, time, format (online text interaction), and participation details for investors. It references the company's 2023 half-year report already disclosed on the Shanghai Stock Exchange website but does not contain the report itself or detailed financial data. The document is short (1447 characters) and serves as a notice for the upcoming investor presentation event rather than the presentation or report itself. Therefore, it fits the category of an Investor Presentation announcement or notice. Given the nature of the document as a meeting announcement for an investor-focused event discussing financial results, the best classification is Investor Presentation (IP).
2023-08-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.